Clinical trial
A Phase IV Study in Subjects With Neurogenic Orthostatic Hypotension
NCT00046163 · Shire, Industry · Terminated
Key facts
| NCT number | NCT00046163 |
|---|---|
| Title | A Phase IV Study in Subjects With Neurogenic Orthostatic Hypotension |
| Official title | A Phase IV, Multi-Center, Double-Blind, Parallel Group, Randomized, Placebo-Controlled Study to Assess the Clinical Benefit of Three Doses of Midodrine Hydrochloride (ProAmatine®) in Subjects With Neurogenic Orthostatic Hypotension |
| Lead sponsor | Shire, Industry |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Hypotension, Orthostatic |
| Intervention type | Drug |
| Interventions | midodrine hydrochloride (ProAmatine®) |
| Enrollment | 150 |
| Start date | Sep 5, 2002 |
| Primary completion | Aug 6, 2003 |
| Completion | Aug 6, 2003 |
| First posted | Sep 23, 2002 |
| Last update posted | Jun 29, 2021 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: